InsidersTradesSigma
基于 1 个已确定 T+90 收益的买入信号。收益基准：公布次日的收盘价。
Explore the complete record of transactions filed by Pauls Dietrich John, 董事长兼首席执行官. Insider active across 1 company, notably DiaMedica Therapeutics Inc.. Aggregated, 4 filings have been recorded. Breakdown: 3 buys · 0 sell. Total volume traded: €82k. History available since 16 August 2021. The latest transaction was filed on 10 August 2026 (Attribution). Regulator: SEC (Form 4). All data is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
4 条申报中的 4 条
John Pauls is the President and CEO of DiaMedica Therapeutics Inc., a biopharmaceutical company. In his role, he is responsible for the strategic direction of the company and the management of its operations. With experience in the biopharmaceutical sector, he plays a key role in developing new treatments and driving innovation.